Unknown

Dataset Information

0

TLR3/TAK1 signalling regulates rhinovirus-induced interleukin-33 in bronchial smooth muscle cells


ABSTRACT: Background Asthma exacerbations are commonly associated with rhinovirus (RV) infection. Interleukin-33 (IL-33) plays an important role during exacerbation by enhancing Type 2 inflammation. Recently we showed that RV infects bronchial smooth muscle cells (BSMCs) triggering production of interferons and IL-33. Here we compared levels of RV-induced IL-33 in BSMCs from healthy and asthmatic subjects, and explored the involvement of pattern-recognition receptors (PRRs) and downstream signalling pathways in IL-33 expression. Method BSMCs from healthy and severe and non-severe asthmatic patients were infected with RV1B or stimulated with the PRR agonists poly(I:C) (Toll-like receptor 3 (TLR3)), imiquimod (TLR7) and poly(I:C)/LyoVec (retinoic acid-inducible gene 1 (RIG-I)/melanoma differentiation-associated protein 5 (MDA5)). Knockdown of TLR3, RIG-I and MDA5 was performed, and inhibitors targeting TBK1, nuclear factor-?B (NF-?B) and transforming growth factor (TGF)-?-activated kinase 1 (TAK1) were used. Gene and protein expression were assessed. Results RV triggered IL-33 gene and protein expression in BSMCs. BSMCs from patients with non-severe asthma showed higher baseline and RV-induced IL-33 gene expression compared to cells from patients with severe asthma and healthy controls. Furthermore, RV-induced IL-33 expression in BSMCs from healthy and asthmatic individuals was attenuated by knockdown of TLR3. Inhibition of TAK1, but not NF-?B or TBK1, limited RV-induced IL-33. The cytokine secretion profile showed higher production of IL-33 in BSMCs from patients with non-severe asthma compared to healthy controls upon RV infection. In addition, BSMCs from patients with non-severe asthma had higher levels of RV-induced IL-8, TNF-?, IL-1?, IL-17A, IL-5 and IL-13. Conclusion RV infection caused higher levels of IL-33 and increased pro-inflammatory and Type 2 cytokine release in BSMCs from patients with non-severe asthma. RV-induced IL-33 expression was mainly regulated by TLR3 and downstream via TAK1. These signalling molecules represent potential therapeutic targets for treating asthma exacerbations. Rhinovirus-induced IL-33 is overexpressed in bronchial smooth muscle cells from asthmatics, and the production of IL-33 following infection is mediated by activation of TLR3 and downstream TAK1 signallinghttps://bit.ly/3fXH0h3

SUBMITTER: Ramu S 

PROVIDER: S-EPMC7533303 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

Similar Datasets

2023-05-02 | PXD015604 | Pride
| S-EPMC6956660 | biostudies-literature
| S-EPMC3574065 | biostudies-literature
| S-EPMC5039037 | biostudies-literature
| S-EPMC3639170 | biostudies-literature
| S-EPMC6035355 | biostudies-literature
| S-EPMC2973831 | biostudies-literature
| S-EPMC5821216 | biostudies-literature
| S-EPMC8478401 | biostudies-literature
| S-EPMC7055698 | biostudies-literature